KNSA insiders

18 insiders have filed at KNSA since 2023Q3: names, roles, reported stakes, and each person's buying and selling record from SEC Form 3/4/5 filings.

namerolereported stake% of companybuys (3y)sells (3y)
Baker JulianDirector2.75M3.341%
Baker Bros. Advisors LpDirector2.75M3.341%
Baker Bros. Advisors (gp) LlcDirector2.75M3.341%
Baker Brothers Life Sciences LpDirector2.75M3.341%
Baker FelixDirector2.75M3.341%
667, L.P.Director2.75M3.341%
Patel Sanj KChairman & CEO221.6k0.269%20 sells $20.0M
Malley ThomasDirector84.5k0.103%3 sells $5.9M
Paolini John F.Chief Medical Officer61.3k0.074%22 sells $9.7M
Megna Michael RChief Accounting Officer27.0k0.033%13 sells $5.0M
Levy Richard SDirector19.2k0.023%
Tessari EbenChief Operating Officer16.7k0.02%34 sells $19.7M
Mccain Tracey LDirector12.5k0.015%
Popovits Kimberly JDirector12.5k0.015%
Cole G BradleyDirector12.5k0.015%
Quart Barry DDirector12.5k0.015%9 sells $2.5M
Ragosa MarkChief Financial Officer12.1k0.015%24 sells $12.5M
Moat RossChief Corp. & Comm. Officer9.4k0.011%9 sells $5.6M

Full register at boothcheck.com/insiders/KNSA. Stakes are the newest reported Form 3/4/5 balances (they update only when insiders file). Sales counted include pre-scheduled plan sales, labeled. A filed record, not a forecast. Nothing here is investment advice.

KNSA institutional holders · KNSA research report